AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Remifav 100mg Injection

Prescription Icon
Prescription Required

Marketer

Favnox Pharmaceuticals Private Limited

Salt Composition

Remdesivir (100mg)

Overview Remifav 100mg Injection

Remifav 100mg injection is a wide-ranging antiviral medication indicated for hospitalized adults and children with severe, confirmed or suspected COVID-19. This intravenous injection reduces viral burden and accelerates recovery. Its mechanism involves inhibiting RNA polymerase, a vital enzyme for SARS-CoV-2 replication. Administration requires a physician's oversight and strict adherence to the prescribed dosage and duration; self-medication is strictly prohibited. Common adverse events include elevated blood glucose, anemia, acute kidney injury, increased liver enzymes (transaminases), and fever. Report any allergic reaction or concerning side effect immediately to your physician. Caution is advised for pregnant or breastfeeding individuals, as well as the elderly and pediatric patients.

Uses of Remifav 100mg Injection

Managing Coronavirus Infection (COVID-19)

Major Benefits of Remifav 100mg Injection:

This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

Common Side effects of Remifav 100mg Injection:

  • Headache
  • Rash
  • Extravasation
  • Increased prothrombin time
  • Increased transaminase level in blood

How to use Remifav 100mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Remifav 100mg Injection works:

Remifav 100mg Injection is a wide-ranging antiviral medication. Its mechanism of action involves the suppression of RNA polymerase, an RNA-dependent enzyme crucial for SARS-CoV-2 replication. This inhibition consequently reduces the viral burden within the patient.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Remifav 100mg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Remifav 100mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Remifav 100mg Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Remifav 100mg Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Remifav 100mg Injection's use in individuals with renal impairment. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Remifav 100mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Remifav 100mg Injection :

NA

Facts to Know About Remifav 100mg Injection

LabelValue
Chemical Classification Amino acid alpha esters
Developing Habits No.
Treatment Category Antimicrobials

FAQs on Remifav 100mg Injection

COVID-19, caused by the novel SARS-CoV-2 virus, is a highly contagious respiratory illness. This newly emerged virus primarily affects the lungs, leading to symptoms such as fever, cough, and shortness of breath.
Remifav 100mg Injection, an antiviral medication, has demonstrated effectiveness in managing severe COVID-19 in recent laboratory studies of hospitalized patients. While not currently approved for COVID-19 treatment, some studies indicate faster recovery in patients receiving Remifav 100mg Injection compared to other treatments. However, its safety and efficacy for COVID-19 remain under investigation, with ongoing clinical trials.
The Food and Drug Administration (FDA), under the authority of the Food, Drug, and Cosmetic Act, issues Emergency Use Authorizations (EUAs) for medical products—including medicines, vaccines, and devices—to combat serious health threats like the COVID-19 pandemic. An EUA allows the use of a product even without full FDA approval, balancing potential benefits against known risks during a public health emergency.
Remifav 100mg Injection is administered intravenously by a doctor only to hospitalized children and adults with severe COVID-19. Severe COVID-19 is defined as SpO2 ≤94% on room air or the need for supplemental oxygen, mechanical ventilation, or ECMO. Self-administration is strictly prohibited. Always follow your doctor's instructions for optimal results.
The EU has authorized Remifav 100mg Injection for hospitalized patients with severe COVID-19, demonstrating accelerated recovery from serious respiratory distress in both adults and children.
Clinical trials are ongoing for Remifav 100mg Injection, which has shown promise in inhibiting SARS-CoV-2 replication. This reduces the viral load, potentially accelerating recovery from COVID-19.
Remifav 100mg Injection may cause anemia, fever, kidney damage, nausea, vomiting, shivering, sweating, low blood pressure, and elevated liver enzymes. However, this is not an exhaustive list of potential side effects, and further research is needed. The use of Remifav 100mg Injection in treating Covid-19 is under investigation, and additional risks may exist.
Insufficient data exists to confirm the safety and efficacy of Remifav 100mg Injection for treating hospitalized adults and children with severe COVID-19. Its use in this population is conditional, balancing potential benefits against known and unknown risks. Ongoing clinical trials are underway, and the drug's safety profile remains undetermined.
Limited data exists on Remifav 100mg Injection's use in treating COVID-19. Its safety and effectiveness in pregnant or breastfeeding women are unknown. If you are pregnant, breastfeeding, or planning a pregnancy, consult your doctor if you have or suspect a COVID-19 infection. They will determine the appropriate course of treatment based on your individual circumstances.
Inform your doctor of all medical conditions, including kidney or liver problems, serious illnesses (like heart disease or diabetes), and allergies before receiving Remifav 100mg Injection. Disclose all medications you're taking—prescription, over-the-counter, vitamins, or herbal products—as Remifav 100mg Injection may interact with them. Specifically mention any medications containing chloroquine phosphate or hydroxychloroquine sulfate. Also, tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Remifentanil 100mg Injection is not indicated for COVID-19 prevention; its efficacy in this context is unsupported by evidence.
The Indian Drug Controller General (DCGI) has granted emergency authorization for Remifav 100mg Injection due to the pandemic. Its use is restricted to proven COVID-19 cases with clinical indication; it is not approved for preventative or suspected cases.
Remifav 100mg Injection
3,888
MRP 4,500
13% off